Reference Guide to Microplate Chemical Compatibil?ity
Porvair Sciences has announced a new version of its Chemical Compatibility Chart that provides an easy-to-use reference guide detailing the chemical resistance of membranes and matrices used in microplates to a wide range of common laboratory chemicals.
Employing tests performed at room temperature (25°C), Porvair has compiled data as to the compatibility of different microplate matrices and membranes to a wide range of acids, alcohols, bases, esters, hydrocarbons/chlorinated hydrocarbons, ketones and other chemicals. In the tabulated chart, chemical compatibility data for each microplate material is listed as ‘suitable’, ‘ok for medium-term use’ or ‘unsuitable’ thereby offering lab scientists the information to enable selection of just microplates constructed from materials optimised for their application.
A copy of the chemical compatibility chart is included in the Porvair Sciences catalogue of microplates and microplate equipment which may be downloaded from the homepage of www.porvair-sciences.com
Combining uncompromising high quality with an affordable price, Porvair Sciences offers an extensive range of deep well, shallow well, storage, assay, SPE, protein precipitation and filtration microplates. Precisely manufactured in an ISO 9001 production cleanroom to comply with SLAS / ANSI dimensions ensures Porvair microplates are completely compatibility with all automated sample handling systems, microplate readers and washers.
For further information please contact Porvair Sciences on +44 1372 824 290 or email [email protected]
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance